Immunome, Inc. IMNM
18.70 USD -0.37 (-1.94%)
At closeNov 12, 2026, 4:26 PM EST
18.70 0.00 0.00%
After hours · Nov 12, 4:26 PM ET
18.02 Day range 19.06
16.11 52-week range 30.06
- YTD
- -12.94%
- 1 year
- +7.29%
IMNM revenue history
Revenue is income from the company’s ordinary business activities.
6,941,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | 6,941,000 | -2,100,000 | -23.23% |
| FY 2024 | 2024-12-31 | 9,041,000 | -4,977,000 | -35.50% |
| FY 2023 | 2023-12-31 | 14,018,000 | 14,018,000 | Not meaningful |
| FY 2022 | 2022-12-31 | 0 | 0 | Not meaningful |
| FY 2021 | 2021-12-31 | 0 | 0 | Not meaningful |
| FY 2020 | 2020-12-31 | 0 | 0 | Not meaningful |
| FY 2019 | 2019-12-31 | 0 | 0 | Not meaningful |
| FY 2018 | 2018-12-31 | 0 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-05-22T14:42:22.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.